ciraparantag
ciraparantag: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| AMAG PHARMACEUTICALS, INC. (AMAG) | Phase 2 |
Clinical Trials (1)
Phase 2 Placebo-Controlled, Single-Site, Single-Blind Study of Apixaban Reversal by Ciraparantag as Measured by WBCT
Frequently asked questions
Who is developing ciraparantag?
ciraparantag is being developed by AMAG PHARMACEUTICALS, INC..
How many clinical trials involve ciraparantag?
BioSniper tracks 1 clinical trial involving ciraparantag.
Get deeper analysis on ciraparantag
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis